Biotechnology Value Fund L P - Dec 31, 2024 SCHEDULE 13G/A Report for Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Ikena Oncology, Inc. Common Stock, par value $0.001 per share
Symbol
IKNA
Shares outstanding
48.3M shares
Disclosed Ownership
4.01M shares
Ownership
8.3%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:22 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 4.3% 2.07M 0 2.07M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 4.3% 2.07M 0 2.07M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.5% 1.67M 0 1.67M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.5% 1.67M 0 1.67M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 209K 0 209K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 209K 0 209K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 7.7% 3.74M 0 3.74M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 8.3% 4.01M 0 4.01M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 8.3% 4.01M 0 4.01M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 8.3% 4.01M 0 4.01M /s/ Mark N. Lampert Mark N. Lampert